Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced promotions in its Commercial Team including Benoit Chardon to Chief Commercial Officer, Camillo Docimo to Vice President of Program Excellence, and Javier Ibanez to Vice President of International Sales.
"I am delighted to announce the promotion of these talented leaders in our Commercial Team," said Shantanu Gaur, M.D., Allurion’s co-founder and Chief Executive Officer. "Their contributions have led Allurion to unprecedented levels of revenue growth, account productivity, marketing efficiency, and expansion to over 40 countries all while cultivating a best-in-class culture throughout our organization."
Benoit Chardon joined Allurion in 2018 with over 20 years of experience in successful new category creation and served as Vice President, Global Commercial before being promoted to Executive Vice President in 2019. As Chief Commercial Officer, Mr. Chardon will oversee Allurion’s global commercial operations and lead a variety of strategic initiatives to further accelerate growth, utilization, and territory expansion while increasing efficiencies to drive both top and bottom-line performance.
Camillo Docimo joined Allurion in 2016 with over 25 years of experience in sales, business development, and clinical affairs in the weight loss industry. As Vice President of Program Excellence, Mr. Docimo and his team will lead initiatives to increase consumer and provider satisfaction, improve program outcomes, and translate the insights from Allurion’s Virtual Care Suite into clinical practice.
Javier Ibanez joined Allurion in 2019 with over 30 years of experience in medical device sales, business development, and finance. As Vice President of International Sales, Mr. Ibanez will lead the global sales team across 40 countries today with a plan to expand to over 60 countries in the next three years.
"It has been a privilege to scale Allurion’s weight loss program around the world over the past three years and to positively impact the lives of over 40,000 consumers and the 300 providers we serve," said Mr. Chardon. "In this next phase of growth, we will leverage the foundation we have built to date to establish ourselves as a medical weight loss category leader globally."
About Allurion Technologies
Allurion Technologies is dedicated to helping people realize a healthy life with innovative, scalable and trusted weight loss experiences. The company's flagship product, the Allurion Program, is a 360-degree weight loss experience featuring the Elipse Balloon, the world’s first and only swallowable, procedureless gastric balloon for weight loss, the Allurion Honeymoon from Hunger nutritional and behavior change program, and the Allurion Virtual Care Suite including the Allurion Connected Scale, Allurion Health Tracker watch, Allurion mobile app, Allurion Clinic Dashboard and Allurion Insights Portal. Learn more about Allurion online at www.allurion.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210309005040/en/